The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2009

Filed:

Mar. 29, 2006
Applicants:

Lea Eisenbach, Rehovot, IL;

Lior Carmon, Tel-Aviv, IL;

Boaz Tirosh, Kiryat Ono, IL;

Adrian Paz, Petach Tikva, IL;

Matityahu Fridkin, Rehovot, IL;

Inventors:

Lea Eisenbach, Rehovot, IL;

Lior Carmon, Tel-Aviv, IL;

Boaz Tirosh, Kiryat Ono, IL;

Adrian Paz, Petach Tikva, IL;

Matityahu Fridkin, Rehovot, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to tumor associated antigen (TAA) peptides and to use of same, of polynucleotides encoding same and of cells presenting same as anti-tumor vaccines. More particularly, the present invention relates to tumor associated antigen peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen (PSA), Prostate acid phosphatase (PAP) and Prostate specific membrane antigen (PSMA), BA-46 (Lactadherin), Mucin (MUC-1), and Teratocarcinoma-derived growth factor (CRIPTO-1) and the use of same as anti-tumor vaccines to prevent or cure bladder, prostate, breast or other cancers, carcinomas in particular. Most particularly, the present invention relates to tumor associated antigen peptides which are presentable to the immune system by HLA-A2 molecules.


Find Patent Forward Citations

Loading…